Ubrigene Secures RMB 150 Million in Series C+ Financing to Expand Global CGT CDMO Platform
Yiming Cell Biotechnology Co., Ltd, known as Ubrigene Biosciences Inc., a leading gene and cell...
NMPA & FDA Filing
Huadong Medicine Reports 9.12% YOY Revenue Growth and 13.24% Increase in Net Profits for 2022
Huadong Medicine Co., Ltd (SHE: 000963), a leading China-based pharmaceutical company, has released its 2022...
Allorion Therapeutics Raises USD 50 Million in Series B Financing to Advance Drug Development
Allorion Therapeutics, a next-generation precision medicine small molecule drug developer based in Guangzhou, reportedly raised...
Jing Medicine’s HJM-353 Gains Clinical Trial Approvals in US and China
China-based Jing Medicine Technology (Shanghai) Co., Ltd’s HJM-353 has obtained clinical trial approvals in the...
Innoforce Partners with RNAimmune for mRNA Development and Production
Hangzhou-based biopharma partner company Innoforce Pharmaceuticals Co., Ltd struck a partnership with RNAimmune, a spin-off...
MicroPort MedBot’s Orthopedic Surgery Robot Receives CE Certification
Shanghai MicroPort MedBot (Group) Co., Ltd (HKG: 2252) announced receiving a CE certification in Europe...